Cite
HARVARD Citation
Sharma, J. et al. (2021). Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy. Therapeutic advances in drug safety. p. . [Online].